1102 Bates St., Ste. 1770
Houston, TX 77030
Dr. Christopher DeRenzo is a graduate from the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School where he received his medical degree. Following his graduation, Dr. Derenzo completed a medical residency at Case Western Reserve, Rainbow Babies and Children’s Hospital in Cleveland, Ohio. He underwent the Doris Duke Research Fellowship in Dallas, TX where he worked in a translational research laboratory constructing 3-dimensional models of bronchial epithelium and lung cancer. Dr. Derenzo completed his specialty training at Texas Children’s Cancer Center, where he completed his Fellowship in Pediatric Hematology-Oncology through Baylor College of Medicine.
He is also a graduate and former student President of Rutgers Business School at Rutgers University where he received his Masters of Business Administration in 2004 and was designated as a Henry Rutgers Scholar.
Dr. Christopher DeRenzo is a member of the Center for Cell and Gene Therapy (CAGT) and the Solid Tumor Programs. His clinical activities include: the treatment of pediatric solid tumors and immunotherapy of pediatric solid tumors.
He is board certified by the American Board of Pediatrics.
MD, Rutgers Robert Wood Johnson Medical School
MBA, Rutgers Business School
BA, Rutgers University
Pediatric Hematology-Oncology Fellowship, Baylor College of Medicine, Texas Children’s Hospital
Pediatric Residency, Case Western Reserve, Rainbow Babies and Children’s Hospital
Dr. DeRenzo’s research is focused on harnessing the body’s immune system to treat pediatric patients with solid tumors. Specifically, he works with T cells, and his efforts are aimed at developing novel methods to enhance T-cell therapies for pediatric patients with solid tumors.
Dr. DeRenzo’s research is performed under the mentorship of Dr. Stephen Gottschalk in the Center for Cell and Gene Therapy (CAGT) at Baylor College of Medicine and Texas Children’s Cancer Center.
In June 2014, during his fellowship training at Baylor College of Medicine, the Rally Foundation for Childhood Cancer Research (rallyfoundation.org) awarded DeRenzo with a $50,000 grant to support his project on using immunotherapy to treat pediatric patients with solid tumors and brain tumors. This grant is co-funded with The Truth 365 (www.thetruth365.org).
American Society of Clinical Oncology (ASCO)
American Society of Pediatric Hematology/Oncology (ASPHO)
Children’s Oncology Group (COG)
Society for the Immunotherapy of Cancer (SITC)